UnitedHealth Group (UNH.US) is the worst performing S&P 500 stock today and drops around 5% on the day. The drop comes after Bloomberg reported that US Department of Justice launched an antitrust investigation into the company.
Bloomberg report is based on the information provided by an anonymous informant suggests that regulatory concerns primarily focus on the conversion of the insurance branch's customers into customers of the Optum executive arm. The most well-known insurance unit of the company, UnitedHealthcare, covering over 47 million Americans, is gaining a growing share of revenues and profits from companies providing healthcare services under its Optum executive arm. Optum clinics offering home care services, creating drug plans, and delivering medications often provide services to UnitedHealthcare members, allowing the company to transform insurance-related expenses into revenue for Optum. This arrangement has historically helped drive the growth of UnitedHealth.
Start investing today or test a free demo
Open account Try demo Download mobile app Download mobile appTaking a look at UnitedHealth chart (UNH.US) at D1 interval, we can see that the stock is plunging below 200-session moving average (purple line) and $505 support zone today. Stock is trading at the lowest level since January 24, 2024. The near-term support zone to watch should declines continue can be found in the $475 area.
Source: xStation5
This content has been created by XTB S.A. This service is provided by XTB S.A., with its registered office in Warsaw, at Prosta 67, 00-838 Warsaw, Poland, entered in the register of entrepreneurs of the National Court Register (Krajowy Rejestr Sądowy) conducted by District Court for the Capital City of Warsaw, XII Commercial Division of the National Court Register under KRS number 0000217580, REGON number 015803782 and Tax Identification Number (NIP) 527-24-43-955, with the fully paid up share capital in the amount of PLN 5.869.181,75. XTB S.A. conducts brokerage activities on the basis of the license granted by Polish Securities and Exchange Commission on 8th November 2005 No. DDM-M-4021-57-1/2005 and is supervised by Polish Supervision Authority.
